BRPI0607803A2 - forma de dosagem oral compreendendo rosiglitazona - Google Patents
forma de dosagem oral compreendendo rosiglitazonaInfo
- Publication number
- BRPI0607803A2 BRPI0607803A2 BRPI0607803-6A BRPI0607803A BRPI0607803A2 BR PI0607803 A2 BRPI0607803 A2 BR PI0607803A2 BR PI0607803 A BRPI0607803 A BR PI0607803A BR PI0607803 A2 BRPI0607803 A2 BR PI0607803A2
- Authority
- BR
- Brazil
- Prior art keywords
- dosage form
- composition
- oral dosage
- rosiglitazone
- pharmaceutically acceptable
- Prior art date
Links
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 title abstract 5
- 239000006186 oral dosage form Substances 0.000 title abstract 3
- 229960004586 rosiglitazone Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 3
- 239000002552 dosage form Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
FORMA DE DOSAGEM ORAL COMPREENDENDO ROSIGLITAZONA. Uma forma de dosagem oral, tal como um comprimido em bicamada compreendendo uma primeira camada de uma primeira composição e uma segunda camada de uma segunda composição, cada composição compreendendo 5-[4-[2-(N-metil-N-(2 piridil)amino)etóxi]benzil]tiazolidina-2,4-diona ou um sal ou solvato farmaceuticamente aceitável deste, ('a droga') e um veículo farmaceuticamente aceitável para este, em que a primeira e a segunda composição são organizadas para liberar droga em taxas de liberação diferentes na administração; um processo para preparar tal forma de dosagem e o uso de tal forma de dosagem na medicina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0502475.7A GB0502475D0 (en) | 2005-02-07 | 2005-02-07 | Novel compositions |
| PCT/EP2006/000997 WO2006087116A1 (en) | 2005-02-07 | 2006-02-03 | Oral dosage form comprising rosiglitazone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0607803A2 true BRPI0607803A2 (pt) | 2009-06-13 |
Family
ID=34355898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0607803-6A BRPI0607803A2 (pt) | 2005-02-07 | 2006-02-03 | forma de dosagem oral compreendendo rosiglitazona |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20080166408A1 (pt) |
| EP (1) | EP1855671A1 (pt) |
| JP (1) | JP2008543723A (pt) |
| KR (1) | KR20070110016A (pt) |
| CN (1) | CN101155586A (pt) |
| AU (1) | AU2006215854A1 (pt) |
| BR (1) | BRPI0607803A2 (pt) |
| CA (1) | CA2595411A1 (pt) |
| EA (1) | EA200701681A1 (pt) |
| GB (1) | GB0502475D0 (pt) |
| IL (1) | IL184790A0 (pt) |
| MA (1) | MA29281B1 (pt) |
| MX (1) | MX2007009492A (pt) |
| NO (1) | NO20074407L (pt) |
| TW (1) | TW200700063A (pt) |
| WO (1) | WO2006087116A1 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0203296D0 (en) * | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
| US8637512B2 (en) * | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
| EP1967182A1 (en) * | 2007-03-07 | 2008-09-10 | KRKA, tovarna zdravil, d.d., Novo mesto | Pharmaceutical composition comprising a salt of rosigliatazone |
| US20100323016A1 (en) * | 2008-07-18 | 2010-12-23 | Biljana Nadjsombati | Modified release formulation and methods of use |
| US20100323015A1 (en) * | 2008-07-18 | 2010-12-23 | Biljana Nadjsombati | Modified release formulation and methods of use |
| MX2011000636A (es) * | 2008-07-18 | 2011-08-03 | Valeant Pharmaceuticals Int | Formulacion de liberacion modificada y metodos de uso. |
| CA2848798C (en) * | 2012-02-22 | 2014-12-23 | Duchesnay Inc. | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof |
| US9452181B2 (en) | 2013-07-22 | 2016-09-27 | Duchesnay Inc. | Composition for the management of nausea and vomiting |
| BR112016001474A2 (pt) | 2013-07-22 | 2020-04-14 | Duchesnay Inc | Composição para o controle de náusea e vômito |
| US9526703B2 (en) | 2014-08-29 | 2016-12-27 | Duchesnay Inc. | Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof |
| LT3684344T (lt) * | 2017-10-25 | 2025-09-10 | Chiesi Farmaceutici S.P.A. | Uždelsto atpalaidavimo deferiprono tabletės ir jų panaudojimo būdai |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5407687A (en) * | 1994-02-22 | 1995-04-18 | Glaxo Inc. | Ranitidine solid dosage form |
| DE69939485D1 (de) * | 1998-11-12 | 2008-10-16 | Smithkline Beecham Plc | Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin |
| TW200517127A (en) * | 2003-08-07 | 2005-06-01 | Sb Pharmco Inc | Novel composition |
| US20050163837A1 (en) * | 2003-12-31 | 2005-07-28 | Garth Boehm | Rosiglitazone formulations |
-
2005
- 2005-02-07 GB GBGB0502475.7A patent/GB0502475D0/en not_active Ceased
-
2006
- 2006-02-03 JP JP2007553549A patent/JP2008543723A/ja not_active Withdrawn
- 2006-02-03 KR KR1020077018029A patent/KR20070110016A/ko not_active Withdrawn
- 2006-02-03 EA EA200701681A patent/EA200701681A1/ru unknown
- 2006-02-03 WO PCT/EP2006/000997 patent/WO2006087116A1/en not_active Ceased
- 2006-02-03 MX MX2007009492A patent/MX2007009492A/es not_active Application Discontinuation
- 2006-02-03 US US11/815,326 patent/US20080166408A1/en not_active Abandoned
- 2006-02-03 CN CNA2006800111173A patent/CN101155586A/zh active Pending
- 2006-02-03 CA CA002595411A patent/CA2595411A1/en not_active Abandoned
- 2006-02-03 BR BRPI0607803-6A patent/BRPI0607803A2/pt not_active IP Right Cessation
- 2006-02-03 AU AU2006215854A patent/AU2006215854A1/en not_active Abandoned
- 2006-02-03 EP EP06742510A patent/EP1855671A1/en not_active Withdrawn
- 2006-02-06 TW TW095103942A patent/TW200700063A/zh unknown
-
2007
- 2007-07-23 IL IL184790A patent/IL184790A0/en unknown
- 2007-08-29 NO NO20074407A patent/NO20074407L/no not_active Application Discontinuation
- 2007-08-31 MA MA30182A patent/MA29281B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1855671A1 (en) | 2007-11-21 |
| KR20070110016A (ko) | 2007-11-15 |
| US20080166408A1 (en) | 2008-07-10 |
| GB0502475D0 (en) | 2005-03-16 |
| AU2006215854A1 (en) | 2006-08-24 |
| TW200700063A (en) | 2007-01-01 |
| IL184790A0 (en) | 2007-12-03 |
| MA29281B1 (fr) | 2008-02-01 |
| MX2007009492A (es) | 2007-09-19 |
| EA200701681A1 (ru) | 2007-12-28 |
| JP2008543723A (ja) | 2008-12-04 |
| NO20074407L (no) | 2007-08-29 |
| WO2006087116A1 (en) | 2006-08-24 |
| CN101155586A (zh) | 2008-04-02 |
| CA2595411A1 (en) | 2006-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP1545A (en) | Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione. | |
| HRP20020416B1 (hr) | Novi pripravak i upotreba | |
| BRPI0616077B8 (pt) | composição farmacêutica formulada em uma dose única, kit, artigo de manufatura, uso da composição farmacêutica e uso de um ou mais compostos antidiabéticos | |
| WO2007126362A8 (en) | Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's disease and/or schizophrenia | |
| NO20074514L (no) | Oral doseringsform omfattende rosiglitazon | |
| BRPI0607803A2 (pt) | forma de dosagem oral compreendendo rosiglitazona | |
| MX2010002584A (es) | Derivados de piperidina como agonistas de receptores muscarinicos. | |
| NO20085271L (no) | Muscarin reseptoragonister som er effektive i behandling av smerte, Alzheimers sykdom og schizofreni | |
| EP1781629A4 (en) | BENZAMIDINE DERIVATIVES, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | |
| AR045330A1 (es) | Forma de dosificacion oral, procedimiento para su preparacion y uso del compuesto 5-(4-(2-(n-metil-n- (2-piridil)amino)etoxi )bencil) tiazolidin-2,4-diona o una sal o solvato farmaceuticamente aceptable del mismo para prepararla | |
| AR059225A1 (es) | Sal de citrato, proceso de preparacion y su actividad en terapia | |
| BRPI0607804A2 (pt) | braçadeira de lámina despeladora com ranhuras de saìda de gordura | |
| AP1715A (en) | The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione | |
| PT1446404E (pt) | Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos | |
| ECSP034469A (es) | Compuesto farmaceutico novedoso | |
| BR0112982A (pt) | Sal tartarato de derivado de tiazolidinadiona | |
| BR0111536A (pt) | Sal de tiazolidinediona para tratamento de diabetes mellitus | |
| GB0021784D0 (en) | Novel pharmaceutical | |
| BR0112984A (pt) | Sais tartarato de derivado de tiazolidinodiona | |
| CY1107421T1 (el) | Τρυγικα αλατα παραγωγου θειαζολιδινοδιονης | |
| CY1107767T1 (el) | Παραγωγο θειαζολιδινοδιονης και χρηση αυτου σαν αντιδιαβητικο | |
| ECSP034528A (es) | Sales de sodio de 5-(4-(n-methyl-n-(2-piridil)amino)etoxi)bencil)tiazolidino-2,4-diona | |
| AR118314A1 (es) | Composición farmacéutica | |
| ECSP003434A (es) | Nuevos compuestos | |
| TH84984B (th) | รูปแบบของการให้ยาทางปากซึ่งประกอบด้วย5-[4-[2-(n-เมธิล-n-(2-ไพริดิล)อะมิโน)เอธอกซี]เบนซิล]ไธอะโซลิดีน-2,4-ไดโอน |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: SMITHKLINE BEECHAM (CORK) LIMITED (IE) Free format text: TRANSFERIDO DE: SB PHARMCO PUERTO RICO INC. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012. |